Taiwan's Medigen Vaccine Biologics Corp. will provide a free polymerase chain reaction (PCR) testing service to recipients of its protein-based COVID-19 vaccine who wish to travel to Japan until the end of 2022, the company announced Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Cross-Strait
Legislature's decision not to kick out TPP lawmaker 'regrettable': MAC
03/12/2026 10:01 PM -
Sports
Taiwan wins 3 golds on Day 1 of World Indoor Tug of War Championships
03/12/2026 09:48 PM -
Society
Taiwan raises water alert for Hsinchu, lowers nighttime supply pressure
03/12/2026 09:42 PM -
Culture
Sports stars among nominees for PTS board of directors
03/12/2026 09:09 PM -
Society
Magnitude 5.7 earthquake shakes eastern Taiwan
03/12/2026 08:25 PM